This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by GARIBALDI, L. R. Articles by ACETO, T. Search for Related Content PubMed PubMed Citation Articles by GARIBALDI, L. R. Articles by ACETO, T., JR.

Serum Luteinizing Hormone Concentrations, as Measured by a Sensitive Immunoradiometric Assay, in Children with Normal, Precocious or Delayed Pubertal Development^*

Department of Pediatrics and Adolescent Medicine, St. Louis University and Glennon Children's Hospital (L.R.G., S.M., R.C., T.A.) St. Louis, Missouri 63104; and the Second Pediatric Division, Gaslini Institute (P.P.) Genoa, Italy 16148

Address all correspondence and requests for reprints to: L. R. Garibaldi, M.D., Pediatric Endocrinology, Glennon Children's Hospital, 1465 South Grand Boulevard, St. Louis, Missouri 63104.

To determine the diagnostic potential of a highly sensitive immunoradiometric assay (IRMA) for LH in children with normal puberty or altered tempo of sexual maturation, we compared serum LH levels by IRMA (LH IRMA) and standard RIA (LH RIA) in children with idiopathic precocious thelarche (IPT; n = 6), idiopathic premature adrenarche (IPA; n = 14), central precocious puberty (CPP; n = 15), and constitutional delay of puberty (DP; n = 15), and 160 control children (79 males and 81 females). Subjects in the latter group were staged, according to their genital or breast development, as early prepubertal (P1_E; age, <8 yr), late prepubertal (P1_L; 8–12 yr), or stage II-V (P2-P5; n = 22–34 for each subgroup). Serum LH IRMA levels in P1_E, IPT, and IPA children were either undetectable (95% of subjects <0.25 IU/L) or barely detectable (5% of subjects, <0.5 IU/L). Serum LH IRMA levels were greater than 0.5 IU/L in 38% of P1_L (mean ± SD for the group, 1.0 ± 1.3 IU/L) and 57% of P2 (1.4 ± 1.3 IU/L); they were greater than 1.0 IU/L in 100% of P3 (2.6 ± 1.3 IU/L), P4 (3.9 ± 2 IU/L), and P5 (8.6 ± 4 IU/L) children. Comparison of serum LH levels between contiguous pubertal stages showed significantly higher LH IRMA concentrations in P3 vs. P1_E, P4 vs. P2, P5 vs. P4 (all P < 0.001), and P3 vs. P1_L (P < 0.05). In contrast, LH RIA values were not significantly different in P1_E (2.0 ± 0.6 IU/L), P1_L (2.3 ± 0.6 IU/L), P2 (2.7 ± 0.9 IU/L), P3 (3.2 ± 1.3 IU/L), and P4 (3.7 ± 2.2 IU/L), although they were higher in P5 (6.8 ± 4 IU/L) than in P4 (P < 0.001). From P1_E to P5 LH IRMA levels increased 38-fold in females and 21-fold in males, while LH RIA increased 4- and 2.1-fold, respectively. Serum LH IRMA correlated significantly with serum testosterone levels in boys from P1_L to P5 (r = 0.76; P < 0.001), while LH RIA levels did not (r = 0.18). Serum LH IRMA concentrations were above the prepubertal range (>0.5 IU/L) in 67% of children with CPP (group average, 1.8 ± 1.4 IU/L) and 87% of children with DP (1.6 ± 1.4 IU/L). In contrast, LH RIA levels were above prepubertal (>3.7 IU/L) in 27% of children with CPP (3.1 ± 1.3 IU/L) and 20% of children with DP (2.8 ± 1.5 IU/L). In conclusion, 1) the high sensitivity of this LH IRMA and the steep increase in LH IRMA levels with puberty allow better separation of pubertal stages than a standard RIA; 2) there appears to be a continuum of LH IRMA levels between P1_L and P2, with a clear-cut increase in P3 children; 3) serum LH IRMA, unlike LH RIA concentrations, correlate well with serum testosterone in late prepubertal and pubertal males and, therefore, appear to more closely reflect in vivo LH bioactivity; and 4) because of its greater ability (2.5- to 4.3-fold that of the RIA) to detect an increase in serum LH concentrations in children with CPP and DP, a random LH IRMA appears to be a more useful screening test than a random LH RIA measurement in the initial evaluation of children with abnormal tempo of sexual maturation. (J Clin Endocrinol Metab 72: 888–898, 1991)

^* This work was supported in part by a biomedical research grant from St. Louis University and a grant from Genentech, Inc.

Received June 18, 1990.

This article has been cited by other articles:

				E. A. M. R. Resende, B. H. J. Lara, J. D. Reis, B. P. Ferreira, G. A. Pereira, and M. F. Borges Assessment of Basal and Gonadotropin-Releasing Hormone-Stimulated Gonadotropins by Immunochemiluminometric and Immunofluorometric Assays in Normal Children J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1424 - 1429. [Abstract] [Full Text] [PDF]

				V. N. Brito, M. C. Batista, M. F. Borges, A. C. Latronico, M. B. F. Kohek, A. C. P. Thirone, B. H. Jorge, I. J. P. Arnhold, and B. B. Mendonca Diagnostic Value of Fluorometric Assays in the Evaluation of Precocious Puberty J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3539 - 3544. [Abstract] [Full Text] [PDF]

				P. A. Lee Laboratory Monitoring of Children With Precocious Puberty Arch Pediatr Adolesc Med, April 1, 1994; 148(4): 369 - 376. [Abstract] [PDF]